REQUEST A DEMO
Total
USD $0.00
Search more companies

Farabi Pharmaceutical Company Public Joint Stock (Iran)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Farabi Pharmaceutical Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Farabi Pharmaceutical Manufacturing Complex which was launched in 1993 to produce oral antibiotics. The complex, located in Isfahan, produces various Penicillin and Cephalosporin-derived antibiotics. Its annual capacity is estimated at 1.2 billion capsules, 45 million suspensions and 360 million film-coated tablets. To guarantee the required clinical effect for its products, Farabi acquires its raw materials from renowned international producers.

Legal Address
Km 15, Shiraz Road, P.O. Box: 81655/179
Isfahan; Esfahan; Postal Code: 8179159137

Contact Details: Purchase the Farabi Pharmaceutical Company Public Joint Stock report to view the information.

Website: http://www.farabipharma.ir

Basic Information
Total Employees:
Purchase the Farabi Pharmaceutical Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Farabi Pharmaceutical Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Farabi Pharmaceutical Company Public Joint Stock report to view the information.
Incorporation Date:
1989
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
4.9%
Purchase this report to view the information.
1.3%
Purchase this report to view the information.
1.1%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Hejrat Distribution Company Public Joint Stock
25.48%
Company Performance
Financial values in the chart are available after Farabi Pharmaceutical Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
78.58%
Total operating revenue
78.44%
Operating profit (EBIT)
53.63%
EBITDA
53.56%
Net Profit (Loss) for the Period
76%
Total assets
60.86%
Total equity
52.42%
Operating Profit Margin (ROS)
-4.3%
Net Profit Margin
-0.28%
Return on Equity (ROE)
8.21%
Debt to Equity Ratio
47.3%
Quick Ratio
0.11%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?